comparemela.com

Latest Breaking News On - Squamous cell - Page 7 : comparemela.com

Perth skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study

/PRNewswire/ OncoBeta® GmbH today announced Perth s Hollywood Private Hospital in Australia is the latest medical facility to participate in the global.

New yorkUnited statesUnited kingdomWestern australiaGold coastSam vohraShannond brownOncobeta gmbJoe cardaciJane moreyTherapeutic nuclear medicineHollywood private hospitalSkin studyPersonalised irradiationAssociate professor joe cardaciMedical director

Spectrum Health offers free skin cancer screenings in May

Skin cancer is the most common cancer in the United States.

United statesPaul wrightAmerican academy of dermatologyNational cancer instituteCutaneous oncology at spectrum healthSpectrum healthCutaneous oncologyAmerican academyCleveland clinicSquamous cellSquamous cell melanomaMerkel cell

Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta s Rhenium-SCT

/PRNewswire/ OncoBeta® GmbH has announced its first Sydney-based patients were treated with Rhenium-SCT® as part of the global phase IV EPIC-Skin Study.

New yorkUnited statesNew south walesUnited kingdomGold coastKen rikard bellSam vohraShannond brownOncobeta gmbPrnewswire oncobetaTherapeutic nuclear medicineSkin studyPersonalised irradiationMedical directorOncobeta australiaPatient reported outcomes

Non-Small Cell Lung Cancer Treatment Regimens

Find current treatment regimens for small cell lung cancer, including options such as pemetrexed, pemetrexed + cisplatin, and vinorelbine.

Non small cell lung cancer treatmentTargeted therapyMetastatic diseaseSystemic therapySquamous cellFirst line therapyaSubsequent therapyaMutation positive

Austrian skin cancer patients take part in EPIC-Skin clinical study

/PRNewswire/ OncoBeta® GmbH today announces the first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised.

New yorkUnited statesUnited kingdomSiroos mirazeiGerhard dahlhoffShannond brownOncobeta gmbPrnewswire oncobetaTherapeutic nuclear medicineWorld cancer research fundHead of the nuclear medicine departmentSkin studyPersonalised irradiationNuclear medicineOttakring hospitalPatient reported outcome measures

vimarsana © 2020. All Rights Reserved.